134 related articles for article (PubMed ID: 1450065)
1. Preclinical antitumour activity and animal toxicology studies of rhizoxin, a novel tubulin-interacting agent.
Hendriks HR; Plowman J; Berger DP; Paull KD; Fiebig HH; Fodstad O; Dreef-van der Meulen HC; Henrar RE; Pinedo HM; Schwartsmann G
Ann Oncol; 1992 Nov; 3(9):755-63. PubMed ID: 1450065
[TBL] [Abstract][Full Text] [Related]
2. Preclinical and phase I studies with rhizoxin to apply a pharmacokinetically guided dose-escalation scheme.
Graham MA; Bissett D; Setanoians A; Hamilton T; Kerr DJ; Henrar R; Kaye SB
J Natl Cancer Inst; 1992 Apr; 84(7):494-500. PubMed ID: 1545439
[TBL] [Abstract][Full Text] [Related]
3. Rhizoxin, a macrocyclic lactone antibiotic, as a new antitumor agent against human and murine tumor cells and their vincristine-resistant sublines.
Tsuruo T; Oh-hara T; Iida H; Tsukagoshi S; Sato Z; Matsuda I; Iwasaki S; Okuda S; Shimizu F; Sasagawa K
Cancer Res; 1986 Jan; 46(1):381-5. PubMed ID: 3753552
[TBL] [Abstract][Full Text] [Related]
4. EO9: a novel bioreductive alkylating indoloquinone with preferential solid tumour activity and lack of bone marrow toxicity in preclinical models.
Hendriks HR; Pizao PE; Berger DP; Kooistra KL; Bibby MC; Boven E; Dreef-van der Meulen HC; Henrar RE; Fiebig HH; Double JA
Eur J Cancer; 1993; 29A(6):897-906. PubMed ID: 8484984
[TBL] [Abstract][Full Text] [Related]
5. [Assessment of antitumor activity rhizoxin for human lung cancer cell lines: a potent new drug for drug-resistant lung cancer].
Takigawa N; Ohnoshi T; Ueoka H; Horiguchi T; Kiura K; Tabata M; Segawa Y; Shibayama T; Genba K; Matsumura T
Gan To Kagaku Ryoho; 1993 Jul; 20(9):1221-6. PubMed ID: 8392827
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of TZT-1027, a novel dolastatin 10 derivative.
Kobayashi M; Natsume T; Tamaoki S; Watanabe J; Asano H; Mikami T; Miyasaka K; Miyazaki K; Gondo M; Sakakibara K; Tsukagoshi S
Jpn J Cancer Res; 1997 Mar; 88(3):316-27. PubMed ID: 9140117
[TBL] [Abstract][Full Text] [Related]
7. In vivo antitumor activity of S 16020-2, a new olivacine derivative.
Guilbaud N; Kraus-Berthier L; Saint-Dizier D; Rouillon MH; Jan M; Burbridge M; Visalli M; Bisagni E; Pierré A; Atassi G
Cancer Chemother Pharmacol; 1996; 38(6):513-21. PubMed ID: 8823492
[TBL] [Abstract][Full Text] [Related]
8. Phase I and pharmacokinetic study of rhizoxin.
Bissett D; Graham MA; Setanoians A; Chadwick GA; Wilson P; Koier I; Henrar R; Schwartsmann G; Cassidy J; Kaye SB
Cancer Res; 1992 May; 52(10):2894-8. PubMed ID: 1581905
[TBL] [Abstract][Full Text] [Related]
9. Tumor selective effect of RS-1541 (palmitoyl-rhizoxin) in M5076 sarcoma and host tissues in vivo.
Tokui T; Maeda N; Kuroiwa C; Sasagawa K; Inoue T; Kawai K; Ikeda T; Komai T
Pharm Res; 1995 Mar; 12(3):370-5. PubMed ID: 7617523
[TBL] [Abstract][Full Text] [Related]
10. Schedule dependence, activity against natural metastases, and cross-resistance of pyrazine diazohydroxide (sodium salt, NSC 361456) in preclinical models in vivo.
Harrison SD; Plowman J; Dykes DJ; Waud WR; Griswold DP
Cancer Chemother Pharmacol; 1990; 25(6):425-9. PubMed ID: 2311170
[TBL] [Abstract][Full Text] [Related]
11. Comparative antitumour activity of vinblastine-isoleucinate and related vinca alkaloids in human tumour xenografts.
Hendriks HR; Langdon S; Berger DP; Breistøl K; Fiebig HH; Fodstad O; Schwartsmann G
Eur J Cancer; 1992; 28A(4-5):767-73. PubMed ID: 1524896
[TBL] [Abstract][Full Text] [Related]
12. Multicentre phase II pharmacological evaluation of rhizoxin. Eortc early clinical studies (ECSG)/pharmacology and molecular mechanisms (PAMM) groups.
McLeod HL; Murray LS; Wanders J; Setanoians A; Graham MA; Pavlidis N; Heinrich B; ten Bokkel Huinink WW; Wagener DJ; Aamdal S; Verweij J
Br J Cancer; 1996 Dec; 74(12):1944-8. PubMed ID: 8980394
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity and cross-resistance of carmethizole hydrochloride in preclinical models in mice.
Waud WR; Plowman J; Harrison SD; Dykes DJ; Anderson WK; Griswold DP
Cancer Chemother Pharmacol; 1992; 30(4):261-6. PubMed ID: 1322803
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of a novel antitumor antibiotic, quinocarmycin citrate (KW2152).
Fujimoto K; Oka T; Morimoto M
Cancer Res; 1987 Mar; 47(6):1516-22. PubMed ID: 2434218
[TBL] [Abstract][Full Text] [Related]
15. Experimental antitumor activity of BMY-28175 a new fermentation derived antitumor agent.
Schurig JE; Rose WC; Kamei H; Nishiyama Y; Bradner WT; Stringfellow DA
Invest New Drugs; 1990 Feb; 8(1):7-15. PubMed ID: 2345072
[TBL] [Abstract][Full Text] [Related]
16. Studies on macrocyclic lactone antibiotics. XI. Anti-mitotic and anti-tubulin activity of new antitumor antibiotics, rhizoxin and its homologues.
Takahashi M; Iwasaki S; Kobayashi H; Okuda S; Murai T; Sato Y; Haraguchi-Hiraoka T; Nagano H
J Antibiot (Tokyo); 1987 Jan; 40(1):66-72. PubMed ID: 3606749
[TBL] [Abstract][Full Text] [Related]
17. A phase I study of rhizoxin (NSC 332598) by 72-hour continuous intravenous infusion in patients with advanced solid tumors.
Tolcher AW; Aylesworth C; Rizzo J; Izbicka E; Campbell E; Kuhn J; Weiss G; Von Hoff DD; Rowinsky EK
Ann Oncol; 2000 Mar; 11(3):333-8. PubMed ID: 10811501
[TBL] [Abstract][Full Text] [Related]
18. Preclinical antitumor activity of a new Vinca alkaloid derivative, S 12363.
Pierré A; Kraus-Berthier L; Atassi G; Cros S; Poupon MF; Lavielle G; Berlion M; Bizzari JP
Cancer Res; 1991 May; 51(9):2312-8. PubMed ID: 2015595
[TBL] [Abstract][Full Text] [Related]
19. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice.
Citarella RV; Wallace RE; Murdock KC; Angier RB; Durr FE; Forbes M
Cancer Res; 1982 Feb; 42(2):440-4. PubMed ID: 7055799
[TBL] [Abstract][Full Text] [Related]
20. Experimental antitumor activity and pharmacokinetics of the camptothecin analog irinotecan (CPT-11) in mice.
Bissery MC; Vrignaud P; Lavelle F; Chabot GG
Anticancer Drugs; 1996 Jun; 7(4):437-60. PubMed ID: 8826613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
